138 related articles for article (PubMed ID: 37704170)
1. Sustained Clinical Response of Acquired Epidermodysplasia Verruciformis to Human Papillomavirus Virus (VPH) Vaccination in a Kidney Transplant Recipient.
Martinez-Molina M; Munera-Campos M; Quer A; Carrascosa JM
Actas Dermosifiliogr; 2024 Jan; 115(1):110-112. PubMed ID: 37704170
[No Abstract] [Full Text] [Related]
2. Acquired Epidermodysplasia Verruciformis in a Solid Organ Transplant Recipient.
di Prinzio A; Torre AC; Mazzuoccolo LD
Actas Dermosifiliogr; 2023; 114(10):911. PubMed ID: 37088290
[No Abstract] [Full Text] [Related]
3. Perianal Epidermodysplasia Verruciformis Associated With Human Papillomavirus 5 After a Renal Transplant.
Edwards L; Reutter JC; Foster TE; Rady PL; Tyring SK
J Low Genit Tract Dis; 2017 Jul; 21(3):e35-e36. PubMed ID: 28504981
[No Abstract] [Full Text] [Related]
4. P53 expression and human papillomavirus infection in transplant recipients and in patients with epidermodysplasia verruciformis.
McGregor JM; McKee PH; Khorshid M; Proby CM
Br J Dermatol; 1996 Feb; 134(2):374. PubMed ID: 8746364
[No Abstract] [Full Text] [Related]
5. Acquired epidermodysplasia verruciformis in a renal transplant recipient--case report.
Mendes AD; Bittencourt Mde J; Moure ER; D'Macêdo CM; Yamaki IN; Araújo DM
An Bras Dermatol; 2014; 89(1):144-6. PubMed ID: 24626660
[TBL] [Abstract][Full Text] [Related]
6. A case of acquired epidermodysplasia verruciformis in a renal transplant recipient clearing with multimodal treatment including HPV (Gardasil) vaccination.
Maor D; Brennand S; Goh MS; Fahey V; Tabrizi SN; Chong AH
Australas J Dermatol; 2018 May; 59(2):147-148. PubMed ID: 28718200
[No Abstract] [Full Text] [Related]
7. Congenital and Acquired Epidermodysplasia Verruciformis: A Series of 7 Cases.
Alturo-Pons A; Alamon-Reig F; Sanmartín Novell V; Vilardell F; Martí RM
Actas Dermosifiliogr; 2023 Feb; 114(2):179-182. PubMed ID: 36055387
[No Abstract] [Full Text] [Related]
8. Acquired epidermodysplasia verruciformis in a renal transplant patient: a case report.
Gale A; Merzel Šabović EK; Kaiser DJ; Starbek Zorko M
Acta Dermatovenerol Alp Pannonica Adriat; 2022 Mar; 31(Suppl):S18-S20. PubMed ID: 35339137
[TBL] [Abstract][Full Text] [Related]
9. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin.
Majewski S; Jabłońska S
Arch Dermatol; 1995 Nov; 131(11):1312-8. PubMed ID: 7503577
[TBL] [Abstract][Full Text] [Related]
10. Acquired epidermodysplasia verruciformis: clinical presentation and treatment update.
Moore S; Rady P; Tyring S
Int J Dermatol; 2022 Nov; 61(11):1325-1335. PubMed ID: 34403500
[TBL] [Abstract][Full Text] [Related]
11. Involvement of human papillomavirus type 20 in epidermodysplasia verruciformis skin carcinogenesis.
Yutsudo M; Tanigaki T; Kanda R; Sasagawa T; Inoue T; Jing P; Yong-Il H; Hakura A
J Clin Microbiol; 1994 Apr; 32(4):1076-8. PubMed ID: 8027315
[TBL] [Abstract][Full Text] [Related]
12. [Acquired epidermodysplasia verruciformis in a renal transplant recipient].
Gómez-Bernal S; Rodríguez-Pazos L; Pereiro-Ferreirós MM; Toribio J
Actas Dermosifiliogr; 2011 Mar; 102(2):159-61. PubMed ID: 21292228
[No Abstract] [Full Text] [Related]
13. [Pathogenesis of human papillomavirus infection in patients with epidermodysplasia verruciformis].
Liang S; Zuo YG; Wang BX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):93-6. PubMed ID: 19317070
[TBL] [Abstract][Full Text] [Related]
14. Epidermodysplasia verruciformis: immunological and clinical aspects.
Jablonska S; Majewski S
Curr Top Microbiol Immunol; 1994; 186():157-75. PubMed ID: 8205840
[No Abstract] [Full Text] [Related]
15. Condyloma and coincidental epidermodysplasia verruciformis acanthoma positive for human papillomavirus-14 and -21.
Bartley B; Cho WC; Rady PL; Dai J; Curry JL; Milbourne A; Tyring SK; Torres-Cabala CA
J Cutan Pathol; 2023 Jan; 50(1):47-50. PubMed ID: 36039682
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of a variety of epidermodysplasia verruciformis-associated human papillomaviruses in psoriatic skin of patients treated or not treated with PUVA.
Weissenborn SJ; Höpfl R; Weber F; Smola H; Pfister HJ; Fuchs PG
J Invest Dermatol; 1999 Jul; 113(1):122-6. PubMed ID: 10417630
[TBL] [Abstract][Full Text] [Related]
17. Epidermodysplasia verruciformis in human immunodeficiency virus-infected patients: a marker of human papillomavirus-related disorders not affected by antiretroviral therapy.
Jacobelli S; Laude H; Carlotti A; Rozenberg F; Deleuze J; Morini JP; Franck N; Gorin I; Avril MF; Dupin N
Arch Dermatol; 2011 May; 147(5):590-6. PubMed ID: 21242344
[TBL] [Abstract][Full Text] [Related]
18. Epidermodysplasia verruciformis-like syndrome in association with systemic lupus erythematosus.
Holmes C; Chong AH; Tabrizi SN; Downes N; Nindl I
Australas J Dermatol; 2009 Feb; 50(1):44-7. PubMed ID: 19178492
[TBL] [Abstract][Full Text] [Related]
19. Association between epidermodysplasia verruciformis-associated human papillomavirus DNA in plucked eyebrow hair and solar keratoses.
Boxman IL; Russell A; Mulder LH; Bavinck JN; ter Schegget J; Green A;
J Invest Dermatol; 2001 Nov; 117(5):1108-12. PubMed ID: 11710920
[TBL] [Abstract][Full Text] [Related]
20. A novel human papillomavirus identified in epidermodysplasia verruciformis.
Harris AJ; Purdie K; Leigh IM; Proby C; Burge S
Br J Dermatol; 1997 Apr; 136(4):587-91. PubMed ID: 9155964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
